A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
The management of patients with Central Nervous System (CNS) malignancies relies on the appropriate classification of these tumors. Recently, the World Health Organization (WHO) has published new criteria underlining the importance of an accurate molecular characterization of CNS malignancies, in or...
Main Authors: | Elena Tirrò, Michele Massimino, Giuseppe Broggi, Chiara Romano, Simone Minasi, Francesca Gianno, Manila Antonelli, Gianmarco Motta, Francesco Certo, Roberto Altieri, Livia Manzella, Rosario Caltabiano, Giuseppe Maria Vincenzo Barbagallo, Francesca Romana Buttarelli, Gaetano Magro, Felice Giangaspero, Paolo Vigneri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.861078/full |
Similar Items
-
Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review
by: Giuseppe Broggi, et al.
Published: (2022-02-01) -
The Insulin/IGF system in colorectal cancer development and resistance to therapy
by: Paolo Giovanni Vigneri, et al.
Published: (2015-10-01) -
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
by: Michele Massimino, et al.
Published: (2018-02-01) -
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
by: Elena Tirrò, et al.
Published: (2021-02-01) -
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
by: Stefania Stella, et al.
Published: (2021-01-01)